BIOMAT Database Logo BIOMAT Database Logo

Proceedings: Antigenicity of converting phages obtained from Clostridium botulinum types C and D. 1975

K Oguma, and H Iida, and M Shiozaki, and K Inoue

UI MeSH Term Description Entries
D001905 Botulinum Toxins Toxic proteins produced from the species CLOSTRIDIUM BOTULINUM. The toxins are synthesized as a single peptide chain which is processed into a mature protein consisting of a heavy chain and light chain joined via a disulfide bond. The botulinum toxin light chain is a zinc-dependent protease which is released from the heavy chain upon ENDOCYTOSIS into PRESYNAPTIC NERVE ENDINGS. Once inside the cell the botulinum toxin light chain cleaves specific SNARE proteins which are essential for secretion of ACETYLCHOLINE by SYNAPTIC VESICLES. This inhibition of acetylcholine release results in muscular PARALYSIS. Botulin,Botulinum Neurotoxin,Botulinum Neurotoxins,Clostridium botulinum Toxins,Botulinum Toxin,Neurotoxin, Botulinum,Neurotoxins, Botulinum,Toxin, Botulinum,Toxins, Botulinum,Toxins, Clostridium botulinum
D003014 Clostridium botulinum A species of anaerobic, gram-positive, rod-shaped bacteria in the family Clostridiaceae that produces proteins with characteristic neurotoxicity. It is the etiologic agent of BOTULISM in humans, wild fowl, HORSES; and CATTLE. Seven subtypes (sometimes called antigenic types, or strains) exist, each producing a different botulinum toxin (BOTULINUM TOXINS). The organism and its spores are widely distributed in nature.
D000956 Antigens, Viral Substances elaborated by viruses that have antigenic activity. Viral Antigen,Viral Antigens,Antigen, Viral
D001435 Bacteriophages Viruses whose hosts are bacterial cells. Phages,Bacteriophage,Phage

Related Publications

K Oguma, and H Iida, and M Shiozaki, and K Inoue
Characterization of bacteriophage nucleic acids obtained from Clostridium botulinum types C and D.
January 1988, Applied and environmental microbiology,
K Oguma, and H Iida, and M Shiozaki, and K Inoue
Isolation and characterization of converting and non-converting phages, harbored in the strains of Clostridium botulinum types C and D isolated in Japan.
October 1991, The Journal of veterinary medical science,
K Oguma, and H Iida, and M Shiozaki, and K Inoue
Mosaic structures of neurotoxins produced from Clostridium botulinum types C and D organisms.
June 1996, Biochimica et biophysica acta,
K Oguma, and H Iida, and M Shiozaki, and K Inoue
Proteases of Clostridium botulinum. 3. Isolation and characterization of proteases from Clostridium botulinum types A,B,C,D and F.
January 1973, Acta veterinaria Scandinavica,
K Oguma, and H Iida, and M Shiozaki, and K Inoue
Proceedings: Immunological specificities of Clostridium botulinum type C and D toxins.
January 1975, Japanese journal of medical science & biology,
K Oguma, and H Iida, and M Shiozaki, and K Inoue
The stability of toxigenicity in Clostridium botulinum types C and D.
January 1976, Journal of general microbiology,
K Oguma, and H Iida, and M Shiozaki, and K Inoue
Detection of Clostridium botulinum types C and D toxin by ELISA.
March 1991, Australian veterinary journal,
K Oguma, and H Iida, and M Shiozaki, and K Inoue
Phage-conversion of toxigenicity in Clostridium botulinum types C and D.
February 1971, Japanese journal of medical science & biology,
K Oguma, and H Iida, and M Shiozaki, and K Inoue
The toxic antigenic factors produced by Clostridium botulinum types C and D.
June 1971, The Onderstepoort journal of veterinary research,
K Oguma, and H Iida, and M Shiozaki, and K Inoue
The antibody response of cattle to Clostridium botulinum types C and D toxoids.
December 1976, The Onderstepoort journal of veterinary research,
Copied contents to your clipboard!